Transcription Factors Overview
Transcription factors work in a group and are in charge of the regulation of gene expression in order to produce a functional gene products throughout the life of the cell, facilitating cell division, cell proliferation, and cell death. Transcription factors are the single largest family of human proteins, estimating to have approximately 1,600-2,000 variants within the human genome.
Transcription Factors Target Validation Services
Ichor Life Sciences offers transcription factor target validation services for the confirmation of therapeutic utility of transcription factors, regulators of gene expression that play a major role in disease mechanisms like cancer, inflammation, and neurodegenerative diseases. Our strategy consists of specialized techniques in protein purification, structural and biophysical biology, cell-based, and in vivo assays to confirm drug targetability of transcription factors. We use CRISPR/Cas9 and RNAi to regulate transcription factor activity within disease-relevant cell models, as measured by effects on gene expression and cellular phenotypes. We conduct biophysical assays, including SPR and ITC to define inhibitor binding kinetics, and structural biology such as X-ray crystallography and NMR to characterizes interaction sites for binding activity. Validation of functional readouts occurs through our in vivo platform, using patient-derived xenografts and mouse models to authenticate target engagement and efficacy.




